At the Pondy Lit Fest 2024, an insightful discussion took place on the future of mRNA technology in malaria vaccine ...

Pfizer's and Moderna's formulas have been the go-to on pharmacy shelves, but Novavax remains an important option.

Epidemiologists and a federal health agency have criticized new COVID-19 guidance from Florida Surgeon General Joseph Ladapo ...

Moderna should not be left off the list of interesting investment opportunities, as the company has one of the best pipelines ...

I am deeply troubled by the growing distrust of science in our society, just at the time when its insights are most needed.

Breakthroughs in the field are rare, but we have an impressive catalogue of possible solutions to real-word problems.

Health Canada has authorized Novavax's updated COVID-19 vaccine that protects against currently circulating variants of the ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1286.5 with a total volume of ...

The latest, highly contagious subvariants are driving infections, but new vaccines may help stem the tide of another wave — ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $75.00. The ...